Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Anaphylactic shock | Anaphylactic shock | postmarketing | x | ||
| Angioedema | Angioedema | postmarketing | x | ||
| Asthma | Asthma | postmarketing | x | ||
| Hypersensitivity | Hypersensitivity | postmarketing | x | ||
| Pruritus | Pruritus | postmarketing | x | x | |
| Shock | Shock | postmarketing | x | ||
| Urticaria | Urticaria | postmarketing | x | ||
| Respiratory distress | Respiratory distress | postmarketing | x | ||
| Localised oedema | Localised oedema | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Ascites chylous | x | x | |||
| Chylothorax | x | x | |||
| Chyluria | x | x | |||
| Lymphoedema | x | x | |||
| Metastatic neoplasm | x | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |